Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis
- 20 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 33 (6) , 1225-1230
Abstract
Selenium is an essential micronutrient in the diet of humans and other mammals. Based largely on animal studies and epidemiological evidence, selenium is purported to be a promising cancer chemopreventive agent. However, the biological mechanisms by which chemopreventive activity takes place are poorly understood. It remains unclear whether selenium acts in its elemental form, through incorporation into organic compounds, through selenoproteins or any combination of these. The purpose of this study was to determine whether selenoproteins mitigate the risk of developing chemically induced mammary cancer. Selenoprotein expression was ablated in mouse mammary epithelial cells through genetic deletion of the selenocysteine (Sec) tRNA gene (Trsp), whose product, designated selenocysteine tRNA, is required for selenoprotein translation. Trsp floxed and mouse mammary tumor virus (MMTV)-cre mice were crossed to achieve tissue-specific excision of Trsp in targeted mammary glands. Eight- to twelve-week-old second generation Trsp(fl/+);wt, Trsp(fl/+);MMTV-cre, Trsp(fl/fl);wt and Trsp(fl/fl);MMTV-cre female mice were administered standard doses of the carcinogen, 7,12-dimethylbenzylbenz[a]antracene. Our results revealed that heterozygous, Trsp(fl/+);MMTV-cre mice showed no difference in tumor incidence, tumor rate and survival compared with the Trsp(fl/+);wt mice. However, 54.8% of homozygous Trsp(fl/f)(l);MMTV-cre mice developed mammary tumors and exhibited significantly shorter survival than the corresponding Trsp(fl/fl);wt mice, where only 36.4% developed tumors. Loss of the homozygous Trsp alleles was associated with the reduction of selenoprotein expression. The results suggest that mice with reduced selenoprotein expression have increased susceptibility to developing carcinogen-induced mammary tumors and that a major protective mechanism against carcinogen-induced mammary cancer requires the expression of these selenoproteins.Keywords
This publication has 48 references indexed in Scilit:
- Glutathione Peroxidase-1 in Health and Disease: From Molecular Mechanisms to Therapeutic OpportunitiesAntioxidants & Redox Signaling, 2011
- Mammalian thioredoxin reductase 1: roles in redox homoeostasis and characterization of cellular targetsBiochemical Journal, 2010
- Current issues of selenium in cancer chemopreventionBioFactors, 2010
- Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breastBreast Cancer Research, 2009
- Molecular mechanisms by which selenoproteins affect cancer risk and progressionBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Mouse Models Targeting Selenocysteine tRNA Expression for Elucidating the Role of Selenoproteins in Health and DevelopmentMolecules, 2009
- Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functionsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- The human selenoproteome: recent insights into functions and regulationCellular and Molecular Life Sciences, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic modelProceedings of the National Academy of Sciences, 2006